Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Biol Cell
2012 Oct 01;2320:4109-17. doi: 10.1091/mbc.E12-05-0367.
Show Gene links
Show Anatomy links
Regulation of axonal growth and neuromuscular junction formation by neuronal phosphatase and tensin homologue signaling.
Li PP
,
Peng HB
.
???displayArticle.abstract???
During the development of the vertebrate neuromuscular junction (NMJ), motor axon tips stop growing after contacting muscle and transform into presynaptic terminals that secrete the neurotransmitter acetylcholine and activate postsynaptic ACh receptors (AChRs) to trigger muscle contraction. The neuron-intrinsic signaling that retards axonal growth to facilitate stable nerve-muscle interaction and synaptogenesis is poorly understood. In this paper, we report a novel function of presynaptic signaling by phosphatase and tensin homologue (PTEN) in mediating a growth-to-synaptogenesis transition in neurons. In Xenopus nerve-muscle cocultures, axonal growth speed was halved after contact with muscle, when compared with before contact, but when cultures were exposed to the PTEN blocker bisperoxo (1,10-phenanthroline) oxovanadate, axons touching muscle grew ~50% faster than their counterparts in control cultures. Suppression of neuronal PTEN expression using morpholinos or the forced expression of catalytically inactive PTEN in neurons also resulted in faster than normal axonal advance after contact with muscle cells. Significantly, interference with PTEN by each of these methods also led to reduced AChR clustering at innervation sites in muscle, indicating that disruption of neuronal PTEN signaling inhibited NMJ assembly. We thus propose that PTEN-dependent slowing of axonal growth enables the establishment of stable nerve-muscle contacts that develop into NMJs.
FIGURE 1:. Expression of PTEN in embryonic Xenopus spinal neurons. (A) PTEN expression in Xenopus tissues was assessed by immunoblotting. Extracts of Xenopus neural tubes (N), myotomal muscle (M), and whole embryos (E) were stained with an anti-PTEN antibody (top blot) and with anti-tubulin antibody to compare protein loading (bottom blot). Molecular weight marker positions are indicated on the right. (B–E) PTEN expression in neurons was examined by immunolabeling. Fixed and permeabilized embryonic spinal neurons were labeled with anti-PTEN and FITC-conjugated secondary antibodies (PTEN; B and C) or secondary antibodies alone (Ctl; D and E). Labeling for PTEN was detected along axons and also in growth cones (C).
FIGURE 2:. Enhancement of axonal growth by the PTEN-inhibitor bpV. Elongating axons in Xenopus nerve–muscle cocultures were examined by time-lapse recordings. The sample images here show axonal growth over 30 min in control cocultures before contact with muscle (Ctl; A and B) and after (Ctl; C and D), and growth after muscle contact in cocultures treated with a PTEN-inhibitor (bpV, 100 nM; E and F). In both control and bpV-treated cultures, axonal growth slowed after touching muscle, but axons exposed to bpV advanced ∼50% faster than control axons. The axon–growth cone position is marked by a white arrowhead at time zero (0′) and by a black arrowhead at 30 min (30′). In 30 min, the control axon advanced 25 μm before target contact (A and B) but <5 μm after contact (C and D). In contrast, addition of bpV caused the axon to grow 23 μm in 30 min after muscle contact (E and F). (G) Quantification of axonal growth speeds in μm/min using distances axons advanced in control and bpV-treated cultures before and after contact with muscle. Mean ± SEM shown; number of axons examined by time-lapse recording: 10 (Ctl-before contact), 12 (Ctl-after contact), 22 (bpV-before contact), 39 (bpV-after contact); t test: *, p = 0.01, relative to control axons before contact with muscle; ^, p = 0.03 compared with control axons after muscle contact; n.s., not significant. For the difference between Ctl-before contact and bpV-before contact, p = 0.17.
FIGURE 3:. Effect of bpV on axonal growth after NMJ formation. Spinal neurons were seeded on muscle cultures to allow NMJ formation. After 12–16 h, control or 100 nM bpV-containing medium was added to the cocultures. (A and B) In control cultures, little growth of the axon was seen at nerve–muscle contact sites within 30 min, but in bpV-treated cultures (C and D), axons were observed to resume active growth during the 30-min recording period. (E) Quantification of axonal growth speeds in untreated (Ctl) and bpV-treated cocultures. Mean ± SEM; t test: *, p = 0.05 compared with Ctl. Arrowheads indicate initial and final positions of the terminal ends of axonal shafts (A–D). Number of axons examined by time-lapse recording: 16 (Ctl-after contact), 11 (bpV-after contact).
FIGURE 4:. Increase in axonal growth speed following the reduction of PTEN expression in neurons. Spinal neurons were isolated from embryos injected with control MO (Ctl-MO; A–C) or PTEN-specific MO(PTEN-MO; D–F) and cocultured with muscle cells obtained from uninjected embryos. Axons with Ctl-MO and PTEN-MO both slowed after contact with muscle, but after touching muscle, PTEN-MO-axons grew nearly as fast as control axons did before muscle contact. Arrowheads indicate initial and final positions of the terminal ends of axons (A, B, D, and E), and the presence of MOs tagged with fluorescein is shown by the fluorescence of the axons (C and F). (G) Immunoblots showing that PTEN expression was knocked down in Xenopus embryos injected with PTEN-MO but not Ctl-MO (top blot); anti-tubulin staining shows protein loading (bottom blot). (H) Quantification of growth speeds of axons with Ctl-MO and PTEN-MO. Mean ± SEM; t test: *, p = 0.02 compared with Ctl-MO-axons before contact with muscle; ^^, p < 0.005 relative to growth speed of Ctl-MO-axons after muscle contact; number of axons examined by time-lapse recording: 8 (Ctl-MO before contact), 30 (Ctl-MO after contact), 15 (PTEN-MO before contact), 33 (PTEN-MO after contact).
FIGURE 5:. Regulation of axonal advance by exogenous PTEN proteins. Spinal neurons were cultured from Xenopus embryos injected with mRNAs encoding GFP (A–C) and GFP-tagged wild-type PTEN (GFP-WT-PTEN; D–F) or catalytically inactive PTEN (GFP-C124S-PTEN; G–I). These neurons were seeded on muscle cells cultured from uninjected embryos, and axonal growth was monitored by time-lapse imaging. After contact with muscle cells, axons overexpressing wild-type PTEN grew more slowly than control GFP axons, whereas axons expressing inactive PTEN grew faster. The advance of axons can be compared using the arrowheads that mark the terminal ends of growth cones; the expression of exogenous proteins in the axons is shown by GFP fluorescence (C, F, and I). (J) The average growth speeds of axons (expressing exogenous proteins) before and after muscle contact were quantified and are shown as mean ± SEM. t test: *, p = 0.04 relative to GFP axons before muscle contact; ^, p = 0.02 compared with GFP axons after contact with muscle. Number of axons examined by time-lapse recording: 7 (GFP-before contact), 11 (GFP-after contact), 12 (GFP-WT-PTEN-before contact), 17 (GFP-WT-PTEN-after contact), 18 (GFP-C124S-PTEN-before contact), 25 (GFP-C124S-PTEN-after contact).
FIGURE 6:. Inhibition of NMJ formation by the PTEN-blocker bpV. NMJ formation in 1-d-old nerve–muscle cocultures (A and C) was examined by labeling AChR clusters with R-BTX (B and D). In control cocultures, AChRs were aggregated in muscle cells at innervation sites (B), but in bpV-treated cultures, nerve-induced AChR clustering was significantly reduced (D) and spontaneously formed AChR clusters or hot spots (h.s.) persisted; arrows point to axon–muscle contacts, arrowheads to nerve-induced AChR clusters. (E) NMJ assembly was quantified as percentages of nerve–muscle contacts with AChR clusters; mean ± SEM shown; t test: **, p < 0.01. Number of nerve–muscle pairs examined: 105 (Ctl), 104 (bpV).
FIGURE 7:. Suppression of NMJ assembly by the down-regulation of neuronal PTEN expression. Spinal neurons from embryos injected with Ctl-MO (A and B) or PTEN-MO (D and E) were cocultured with muscle cells from uninjected embryos; nerve-induced clustering of AChRs was examined by R-BTX labeling (C and F). AChR aggregation at innervation sites was reduced in cocultures using neurons with PTEN-MO compared with those with Ctl-MO, and AChR hot spots (h.s.) were retained in muscle cells innervated by the PTEN-MO neurons (F). Arrows indicate axon–muscle contacts (A and D); green fluorescence shows the presence of fluorescein-tagged MOs in neurons (B and E); and arrowheads mark nerve-induced AChR clusters (C). Quantification of muscle AChR clustering at innervation sites (G) showed that NMJ formation was reduced by ∼40% in cocultures using PTEN-MO neurons compared with those with Ctl-MO neurons; mean ± SEM; t test: *, p = 0.01. Number of nerve–muscle pairs examined: 53 (Ctl-MO), 68 (PTEN-MO).
FIGURE 8:. Reduction in NMJ development following the expression of inactive PTEN in neurons. Spinal neurons expressing GFP (A and B), GFP-WT-PTEN (D and E), or GFP-C124S-PTEN (G and H) were cocultured with normal muscle cells. R-BTX labeling showed that neurons expressing GFP (C) or WT-PTEN (F) induced AChR clustering better than those expressing C124S-PTEN (I). Arrows mark nerve tracks (A, D, and G); arrowheads point to AChR clusters at innervation sites in muscle (C and F); h.s. indicates an AChR hot spot (I); and GFP fluorescence shows the expression of exogenous proteins in neurons (B, E, and H). Quantification of NMJ formation (J) showed that GFP- and WT-PTEN neurons induced AChR clusters at 70–75% of innervation sites, whereas neurons with inactive PTEN triggered AChR aggregation at <50% of the sites at which they contacted muscle cells; mean ± SEM; t test: **, p < 0.01 relative to AChR cluster induction by GFP neurons. Number of nerve–muscle pairs examined: 53 (GFP), 45 (GFP-WT-PTEN), 87 (GFP-C124S-PTEN).
Anderson,
Effects of innervation on the distribution of acetylcholine receptors on cultured muscle cells.
1977, Pubmed,
Xenbase
Anderson,
Effects of innervation on the distribution of acetylcholine receptors on cultured muscle cells.
1977,
Pubmed
,
Xenbase
Baird,
Cerebellar target neurons provide a stop signal for afferent neurite extension in vitro.
1992,
Pubmed
Bernhardt,
Cellular and molecular bases of axonal pathfinding during embryogenesis of the fish central nervous system.
1999,
Pubmed
Bruneau,
Receptor-associated proteins and synaptic plasticity.
2009,
Pubmed
Carnero,
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
2008,
Pubmed
Christie,
PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons.
2010,
Pubmed
Drinjakovic,
E3 ligase Nedd4 promotes axon branching by downregulating PTEN.
2010,
Pubmed
,
Xenbase
Goberdhan,
Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway.
1999,
Pubmed
Gu,
Shc and FAK differentially regulate cell motility and directionality modulated by PTEN.
1999,
Pubmed
Harris,
Axon collaterals in the thalamic reticular nucleus from thalamocortical neurons of the rat ventrobasal thalamus.
1987,
Pubmed
He,
Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.
2007,
Pubmed
Huang,
Neurotrophins: roles in neuronal development and function.
2001,
Pubmed
Hughes,
Molecular architecture of the neuromuscular junction.
2006,
Pubmed
Kishimoto,
Physiological functions of Pten in mouse tissues.
2003,
Pubmed
Li,
Axonal filopodial asymmetry induced by synaptic target.
2011,
Pubmed
,
Xenbase
Li,
Reciprocal regulation of axonal Filopodia and outgrowth during neuromuscular junction development.
2012,
Pubmed
,
Xenbase
Liu,
PTEN enters the nucleus by diffusion.
2005,
Pubmed
Liu,
PTEN deletion enhances the regenerative ability of adult corticospinal neurons.
2010,
Pubmed
Madhavan,
Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
2005,
Pubmed
,
Xenbase
Madhavan,
Involvement of p120 catenin in myopodial assembly and nerve-muscle synapse formation.
2006,
Pubmed
,
Xenbase
Maehama,
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
1998,
Pubmed
McFarlane,
FGF signaling and target recognition in the developing Xenopus visual system.
1995,
Pubmed
,
Xenbase
Mullen,
Ras/p38 and PI3K/Akt but not Mek/Erk signaling mediate BDNF-induced neurite formation on neonatal cochlear spiral ganglion explants.
2012,
Pubmed
Musatov,
Inhibition of neuronal phenotype by PTEN in PC12 cells.
2004,
Pubmed
Myers,
Regulation of axonal outgrowth and pathfinding by integrin-ECM interactions.
2011,
Pubmed
Ning,
PTEN depletion rescues axonal growth defect and improves survival in SMN-deficient motor neurons.
2010,
Pubmed
Ono,
Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
2001,
Pubmed
Park,
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.
2008,
Pubmed
Park,
PTEN/mTOR and axon regeneration.
2010,
Pubmed
Patapoutian,
Trk receptors: mediators of neurotrophin action.
2001,
Pubmed
Peng,
Differential effects of neurotrophins and schwann cell-derived signals on neuronal survival/growth and synaptogenesis.
2003,
Pubmed
,
Xenbase
Peng,
Tissue culture of Xenopus neurons and muscle cells as a model for studying synaptic induction.
1991,
Pubmed
,
Xenbase
Perandones,
Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development.
2004,
Pubmed
Qian,
The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters.
2008,
Pubmed
,
Xenbase
Sanes,
Induction, assembly, maturation and maintenance of a postsynaptic apparatus.
2001,
Pubmed
Schmid,
Bisperoxovanadium compounds are potent PTEN inhibitors.
2004,
Pubmed
Snaddon,
Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus.
2001,
Pubmed
Song,
ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons.
2010,
Pubmed
Song,
The functions and regulation of the PTEN tumour suppressor.
2012,
Pubmed
Steelman,
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.
2008,
Pubmed
Stocker,
Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB.
2002,
Pubmed
Stuermer,
The retinal axon's pathfinding to the optic disk.
2000,
Pubmed
Tamura,
PTEN gene and integrin signaling in cancer.
1999,
Pubmed
Vazquez,
Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction.
2006,
Pubmed
Vitriol,
Growth cone travel in space and time: the cellular ensemble of cytoskeleton, adhesion, and membrane.
2012,
Pubmed
Wan,
Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
2003,
Pubmed
Webber,
Fibroblast growth factors redirect retinal axons in vitro and in vivo.
2003,
Pubmed
,
Xenbase
Wen,
Directional guidance of nerve growth cones.
2006,
Pubmed
Weng,
PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
2001,
Pubmed
Wu,
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
1998,
Pubmed